Kenya recalls Benylin cough syrup over safety concerns
Health & Science
By
Winfrey Owino
| Apr 11, 2024
The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.
Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.
In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.
The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.
READ MORE
Firms list key products with export potential
Direct flights, SGR extension and trade top list of Ruto, Jinping deals
Spirit of Ruto's China trip amid Trump tariffs and need for caution
Jubilee Life Insurance posts Sh2.1b net profit
Kenyan businesses urged to tap into lucrative Chinese market
"Assassin's Creed" games maker Ubisoft accused of illegal data collection
Warning lights flash at Nissan after monster profit warning
KK security rebrands to GardaWorld, eyes seamless integration
YouTube says more than 20 billion videos uploaded in 20 years
Low incomes, few houses: How high rent prices leave tenants with empty pockets
MOST READ
